Company / Debt per Share
IGC Pharma, Inc. Debt per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Debt per Share
$0.00
FY2025
5-year range
$0.00 / $0.01
FY2021-FY2025
Trend
-35.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Debt per Share has declined for 6 consecutive years, from $0.62 in FY2016 to $0.00 in FY2025.
Based on SEC 10-K filings.
0.00 in FY2025 with a 3-year CAGR of -18.1%.
Improved from $0.00 to $0.00 over the past 2 years.
Debt per Share over time
Growth rates
- 3-Year CAGR
- -18.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- IGC Pharma, Inc.'s debt per share has declined for 4 consecutive years.
- In FY2025, debt per share decreased 35.8% year-over-year.
- Peak debt per share was recorded in FY2016.
Company context
Key Data Points
- Altman Z-Score -13.04 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.00 | -35.8% |
| FY2024 | $0.00 | -6.5% |
| FY2023 | $0.00 | -8.3% |
| FY2022 | $0.00 | -57.1% |
| FY2021 | $0.01 | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | $0.02 | -96.9% |
| FY2016 | $0.62 | +147.4% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026